FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: cytori

Sort
E.g., 2013-05-22
E.g., 2013-05-22
Enter a comma separated list of user names.

Cytori Therapeutics, Inc. (NASDAQ:CYTX) reported that they have entered into a strategic equity agreement to evaluate the potential of adipose derived stem and regenerative cells for the treatment of serious illnesses for which there is no fundamental treatment.

Cytori Therapeutics announced before the opening bell that the first preclinical study to demonstrate adipose-derived stem and regenerative cells (ADRCs) significantly improved cardiac function after a heart attack has been published. This preclinical study was reported online ahead of print in the International Journal of Cardiology.

ADVERTISE WITH US